This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
In this video, I will cover recent updates regarding Novo Nordisk (NYSE: NVO). W...
The Eli Lilly & Co. study puts pressure on Novo, whose market value has dropped ...